We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
FG1R | Flynn Gold Limited | 0.015 | 0.008 | 114.29% | 8,555 | 2 |
IPTOB | Impact Minerals Ltd | 0.002 | 0.001 | 100.00% | 499,500 | 2 |
ME1OE | Melodiol Global Health Ltd | 0.002 | 0.001 | 100.00% | 150,745 | 11 |
KNB | Koonenberry gold Ltd | 0.032 | 0.012 | 60.00% | 615,771 | 14 |
NAE | New Age Exploration Limited | 0.0045 | 0.0015 | 50.00% | 6,971,360 | 18 |
SLSO | Solstice Minerals Ltd | 0.048 | 0.014 | 41.18% | 118,299 | 4 |
TEGO | Triangle Energy Global Limited | 0.007 | 0.002 | 40.00% | 7,979,885 | 23 |
AYT | Austin Metals Lld | 0.007 | 0.002 | 40.00% | 141 | 1 |
NIM | Nimy Resources Ltd | 0.059 | 0.015 | 34.09% | 4,664,278 | 411 |
AXP | AXP Energy Limited | 0.002 | 0.0005 | 33.33% | 491 | 1 |
ERG | Eneco Refresh Limited | 0.012 | 0.003 | 33.33% | 223,666 | 3 |
RADNOR, Pa., April 17, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
The U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders, defined as one that affects fewer than 200,000 people in the U.S. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees for the potential submission of a Biologics License Application (BLA), and certain tax credits.
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, and U.S. Renal Care, the largest privately held kidney care provider in the United States, announced today a multi-year agreement to help accelerate home hemodialysis in the U.S.
Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced an exclusive licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. This partnership marks a significant step in harnessing generation 3.0 psychedelic compounds, methods of their preparation, and uses thereof in the treatment of addiction and mental disorders. Dr. Adi Zuloff-Shani, CEO of Clearmind, commented, "We ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 61,577.58 | 294.59 | 0.48% | 1.2T | 6,961,505,960 |
ETH | Ethereum | 3,000.92 | 15.44 | 0.52% | 358.69B | 3,229,492,068 |
USDT | Tether USD | 1.00 | 0.00005 | 0.00% | 97.84B | 399,828,011 |
BNB | Binance Coin | 545.89 | 11.72 | 2.19% | 86.75B | 520,278,851 |
SOL | Solana | 131.22 | -0.850 | -0.64% | 57.4B | 2,088,694,973 |
STETH | stETH | 2,997.61 | 21.05 | 0.71% | 29.2B | 17,197,031 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,291,664,673 |
XRP | Ripple | 0.4909 | -0.0045 | -0.91% | 26.71B | 447,514,449 |
TONCOIN | Wrapped TON Coin | 6.02 | -0.082202 | -1.35% | 20.75B | 197,250,309 |
DOGE | Dogecoin | 0.14496 | -0.0028 | -1.89% | 20.55B | 670,533,194 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions